DK620189A - Prostaglandin e1-analoge og cyclodextrinchlathrater og ikke-toksiske salte deraf samt middel indeholende dem - Google Patents

Prostaglandin e1-analoge og cyclodextrinchlathrater og ikke-toksiske salte deraf samt middel indeholende dem Download PDF

Info

Publication number
DK620189A
DK620189A DK620189A DK620189A DK620189A DK 620189 A DK620189 A DK 620189A DK 620189 A DK620189 A DK 620189A DK 620189 A DK620189 A DK 620189A DK 620189 A DK620189 A DK 620189A
Authority
DK
Denmark
Prior art keywords
cyclodextrinchlathrater
prostaglandin
analogue
toxic salts
toxic
Prior art date
Application number
DK620189A
Other languages
English (en)
Other versions
DK620189D0 (da
Inventor
Masaki Hayashi
Katsuichi Shimoji
Yoshinobu Arai
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of DK620189A publication Critical patent/DK620189A/da
Publication of DK620189D0 publication Critical patent/DK620189D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02—Lithium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK620189A 1977-09-16 1989-12-08 Prostaglandin e1-analoge og cyclodextrinchlathrater og ikke-toksiske salte deraf samt middel indeholende dem DK620189D0 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52110504A JPS6022710B2 (ja) 1977-09-16 1977-09-16 プロスタグランジン類似化合物

Publications (2)

Publication Number Publication Date
DK620189A true DK620189A (da) 1989-12-08
DK620189D0 DK620189D0 (da) 1989-12-08

Family

ID=14537436

Family Applications (3)

Application Number Title Priority Date Filing Date
DK405078A DK405078A (da) 1977-09-16 1978-09-14 Fremgangsmaade til fremstilling af prostaglandinanaloge
DK620189A DK620189D0 (da) 1977-09-16 1989-12-08 Prostaglandin e1-analoge og cyclodextrinchlathrater og ikke-toksiske salte deraf samt middel indeholende dem
DK620289A DK620289A (da) 1977-09-16 1989-12-08 Analogifremgangsmaade og udgangsmateriale til fremstilling af prostaglandin e1-analoge samt cyclodextrinchlathrater og ikke-toksiske salte deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK405078A DK405078A (da) 1977-09-16 1978-09-14 Fremgangsmaade til fremstilling af prostaglandinanaloge

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK620289A DK620289A (da) 1977-09-16 1989-12-08 Analogifremgangsmaade og udgangsmateriale til fremstilling af prostaglandin e1-analoge samt cyclodextrinchlathrater og ikke-toksiske salte deraf

Country Status (19)

Country Link
US (2) US4215142A (da)
JP (1) JPS6022710B2 (da)
AU (1) AU527940B2 (da)
BE (1) BE870531A (da)
CA (1) CA1119169A (da)
CH (2) CH638492A5 (da)
DE (2) DE2840032C2 (da)
DK (3) DK405078A (da)
FR (2) FR2403333A1 (da)
GB (2) GB2006753B (da)
HK (1) HK82185A (da)
HU (1) HU182553B (da)
IE (1) IE47439B1 (da)
IT (2) IT1192580B (da)
LU (1) LU80235A1 (da)
MY (1) MY8600652A (da)
NL (2) NL184467C (da)
SG (1) SG58485G (da)
ZA (1) ZA785230B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2834248A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-pgf tief 2 und delta 2-pge tief 2 -reihe
DE2913856A1 (de) * 1979-04-06 1980-10-23 Hoechst Ag Neue prostaglandinderivate in der 6-keto-pge tief 1 -reihe
US4443478A (en) * 1981-06-29 1984-04-17 Ono Pharmaceutical Co., Ltd. Prostaglandin analogues
JPS58164512A (ja) * 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
JPS59163365A (ja) * 1983-03-08 1984-09-14 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物
DE3401542A1 (de) * 1984-01-18 1985-08-01 Merck Patent Gmbh, 6100 Darmstadt Schwefelhaltige 6-ketoprostaglandine
JPS60181068A (ja) * 1984-02-29 1985-09-14 Teijin Ltd ６−置換プロスタグランジンｅ↓１類およびその製造法
JPS6130554A (ja) * 1984-07-23 1986-02-12 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤
US4755531A (en) * 1986-08-11 1988-07-05 Syntex (U.S.A.) Inc. Thiol esters of 4,5-allenyl prostaglandins and use thereof as antigastric secretion agents
US5219885A (en) * 1987-02-16 1993-06-15 Froelich Juergen Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
DE3704825A1 (de) * 1987-02-16 1988-08-25 Froelich Juergen Prostaglandin e1-derivate als pharmazeutische wirkstoffe und diese verbindungen enthaltende arzneimittel insbesondere zur transkutanen anwendung
DE3708537A1 (de) * 1987-03-13 1988-09-22 Schering Ag 6-oxoprostaglandin-e-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
JPS63202544U (da) * 1987-06-22 1988-12-27
DE69007630T2 (de) * 1989-01-10 1994-07-14 Schoen Bv Hohlraum bildende Faltjalousie.
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
US6576663B2 (en) 1999-12-22 2003-06-10 Alcon, Inc. 6-Keto prostaglandin F1α and analogs for treating dry eye
EP2516412A4 (en) * 2009-12-18 2013-05-29 Apotex Pharmachem Inc PROCESS FOR CLEANING LUBIPROSTON

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034003A (en) * 1974-04-11 1977-07-05 Ono Pharmaceutical Co., Ltd. 15-Cycloalkyl-prostaglandins
IL51189A (en) * 1976-02-04 1985-08-30 Upjohn Co Prostaglandin analogs
US4124601A (en) * 1976-12-30 1978-11-07 The Upjohn Company Certain 5-halo-6,9α-epoxy-14-bromo(or chloro)-PGF1 compounds
US4171447A (en) * 1976-12-30 1979-10-16 The Upjohn Company Tri-halo prostaglandin intermediates
AU511711B2 (en) * 1976-12-30 1980-09-04 Upjohn Company, The 6-Oxo and 5, 6-Dihalo prostaglandin analogues

Also Published As

Publication number Publication date
SG58485G (en) 1986-08-01
US4215142A (en) 1980-07-29
NL184467B (nl) 1989-03-01
ZA785230B (en) 1979-08-29
AU3988678A (en) 1980-03-20
FR2453851A1 (fr) 1980-11-07
GB2079268A (en) 1982-01-20
GB2006753B (en) 1982-08-04
NL184467C (nl) 1989-08-01
FR2453851B1 (fr) 1985-10-25
CA1119169A (en) 1982-03-02
HU182553B (en) 1984-02-28
FR2403333B1 (da) 1982-05-07
GB2079268B (en) 1982-08-11
IT1192580B (it) 1988-04-20
DE2840032A1 (de) 1979-03-29
MY8600652A (en) 1986-12-31
IE47439B1 (en) 1984-03-21
FR2403333A1 (fr) 1979-04-13
LU80235A1 (fr) 1979-06-01
IT1213051B (it) 1989-12-07
GB2006753A (en) 1979-05-10
CH638492A5 (fr) 1983-09-30
BE870531A (fr) 1979-03-15
DK405078A (da) 1979-03-17
NL7809368A (nl) 1979-03-20
US4278688A (en) 1981-07-14
DK620289D0 (da) 1989-12-08
HK82185A (en) 1985-11-01
NL8203068A (nl) 1982-12-01
JPS6022710B2 (ja) 1985-06-03
DK620289A (da) 1989-12-08
DE2840032C2 (de) 1983-12-22
IT7827773A0 (it) 1978-09-15
DE2858094C2 (de) 1986-03-06
IT8619809A0 (it) 1986-03-19
IE781857L (en) 1979-03-16
DK620189D0 (da) 1989-12-08
JPS5444639A (en) 1979-04-09
CH635318A5 (fr) 1983-03-31
AU527940B2 (en) 1983-03-31

Similar Documents

Publication Publication Date Title
DK620189D0 (da) Prostaglandin e1-analoge og cyclodextrinchlathrater og ikke-toksiske salte deraf samt middel indeholende dem
DK51278A (da) Fungicidt middel samt fremgangsmaade og anvendelse heraf
FI780574A (fi) Skyddorgan foer kanter
SE7805879L (sv) Mevalonolaktonderivat
DK370778A (da) Triphenylakenderivater
SE7805141L (sv) Antitumorantracykliner
IT7867363A0 (it) Leghe per gioielli
BR7801801A (pt) Ceifa-trilhadeira para graos
SE7804446L (sv) Tienamycinderivat
SE7803057L (sv) Bensimidazolderivat
NL7807090A (nl) Alpha-acetyleenderivaten van aminen.
SE7805260L (sv) Alkylendiaminderivat
SE7809373L (sv) Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat
SE7801997L (sv) Dipeptidderivat
BR7805779A (pt) Central pcm por intervalos de tempo
SE7805140L (sv) Bensimidazolderivat
AR223160A1 (es) Procedimiento para preparar derivados de 3-aminoalquiltiazolidindiona(2,4)y sus sales
SE7801312L (sv) Oxadiazolopyrimidin-derivat
FI783393A (fi) 2-imino-imidazolidinderivat
ATA700877A (de) Ringbuchmechanik
SE7800022L (sv) Polymera alkoxisilaner
FI780343A (fi) Oxadiazolopyrimidinderivat
SE7803614L (sv) Steriliseringsapparat
SE7807338L (sv) Lipogenesinhibitorer
IT1094211B (it) Derivati semi-sentetici quattro ammino-oleandomicina

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment